Skip to content

Board of Directors

lidds-1

Pontus Ottosson

Chairman of the Board since 2023

Born: 1960

Education: Master of Science, Chalmers University of Technology in Gothenburg

Other assignments: Head of Investments at Chalmers Ventures AB. Chairman of the Board in IPS Particle Technology Sweden AB, Board member in Oxeon AB, InSingulo AB, Industrial Path Solutions AB, AnPrima AB and Prigo AB.

Work experience: Former CEO of Aqilion (former P.U.L.S) and DuoCort Pharma AB and Board member in several start-up companies within Life Science and Tech.

Holdings: 258,750 shares, 0 warrants

Independent in relation to LIDDS AB (publ), its management and the principal shareholders.

lidds-David-Bejker-people

David Bejker

Board member since 2019, Chairman of the Audit committee

Born: 1975

Education: MSc from the Stockholm School of Economics

Other assignments: CEO of Affibody Medical AB and board member of Abliva AB and Amylonix AB

Work experience: CEO of Affibody Medical AB, a company that develops innovative protein drugs, since 2008. Previously at HealthCap, a specialized life science investor.

Holdings: 65,000 shares, 0 warrants

Independent in relation to LIDDS AB (publ), its management and the principal shareholders

lidds-Daniel-Lifveredson-people

Daniel Lifveredson

Board member since 2017

Born: 1976

Education: Master of Science in Industrial Engineering and Management, Chalmers University of Technology in Gothenburg

Other assignments: CEO and owner of Excore AB

Work experience: Worked with Excore as a base since 1998. Excore is active in advising corporate transactions in the segment of medium-sized companies. Long experience in international business. In addition to Excore, Daniel Lifveredson is involved as a partner in a number of businesses.

Holdings: 2,790,929 shares, 0 warrants

Independent in relation to LIDDS AB (publ), its management and the principal shareholders

Johan Lund

Board member since 2022

Born: 1957

Education: MD/PhD Karolinska Institute, Stockholm.

Other assignments: Co-Founder of KyNexis Medicine Development AB and founder of MBS Pharma, CSO and Chairman of the Board of Aqilion, Chairman of the Board of NEOGAP Therapeutics AB, board member and chairman of the remuneration committee of Olink Holding (Nasdaq NYC), board member of Genagon Therapeutics AB and Pelago Bioscience AB.

Work Experience: Former VP of Immunology & Inflammation Research & Early Development, Celgene; SVP and CSO of Immunology & Inflammation, Pfizer; VP of CNS & Pain Research, AstraZeneca and VP Respiratory & Inflammation Research, AstraZeneca. Professor & Chairman, Department of Anatomy & Cell Biology, Medical Faculty, University of Bergen; Associate Professor, Department of Medical Nutrition, Karolinska Institute.

Holdings: 40,180 Shares

Independent in relation to LIDDS AB (publ), its management and the principal shareholders